NCT06877702View on ClinicalTrials.gov

A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants

PHASE1RecruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 19, 2025

Primary Completion Date

October 29, 2025

Study Completion Date

October 29, 2025

Conditions
Healthy Volunteers
Interventions
DRUG

BMS-986460

Specified dose on specified days.

Trial Locations (2)

66219

RECRUITING

ICON Lenexa, Lenexa

WITHDRAWN

Local Institution - 0002, Lenexa

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT06877702 - A Single-dose Study to Evaluate the Safety, Tolerability, Drug Levels, and Relative Biological Availability of Alternate Formulations of BMS-986460 in Healthy Adult Male Participants | Biotech Hunter | Biotech Hunter